Now, the Drug Enforcement Agency (DEA) and a bill in the Missouri General Assembly are looking to make changes to telemedicine.

Vaxart, Inc. (NASDAQ:VXRT), a biotechnology company specializing in the development of oral recombinant vaccines with a market capitalization of approximately $159 million, announced on Monday an ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

The narrative is false that the COVID vaccine was rushed and not properly tested. It and other vaccines are safe and ...

U.S. medical services providers are seeing the greatest numbers of flu cases since the 2009-2010 flu season, the Centers for ...

There are some new tools to help this respiratory virus season: over-the-counter tests that can identify whether an illness ...

San Francisco Mayor David Lurie launched the San Francisco Police Department Hospitality Task Force as he works to clean up ...

Certain antiviral and mAb therapies were shown to lower mortality and hospitalization rates in those infected with SARS-CoV-2 Omicron variants.

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

The results of this study show that the COVID-19 pandemic caused a notable drop in the number of common ophthalmic procedures among Medicare beneficiaries, especially in laser peripheral iridotomy, ...

Recent data from North Carolina schools reveals a decline in overall crime rates for the first time since the pandemic, yet ...

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.